Annual report 2018

Galenica annual report 2018 | 27 Galexis also launched its new own brand range «Felan» for independent pharmacies in autumn 2018. The «Felan» range comprises cost-effective pharmaceutical and OTC products such as medicines containing paracetamol, where the pack- aging can be personalised with the logo of the relevant pharmacy. Through this new offering, Galexis is supporting independent pharmacists in positioning themselves in the eyes of their customers and strengthening customer loyalty. High demand for services in Ticino Unione Farmaceutica Distribuzione (UFD) had a very good year in 2018. Thanks to the high quality of its services, addi- tional services and strong customer loyalty, UFD was able to gain more than ten new customers and local exporters. Demand for logistics services also increased in Ticino. Accordingly, UFD optimised its delivery runs in the second half of the year to increase punctuality while also reducing the number of kilometres driven. Medifilm: development of new blistering machines As of the end of 2018, Medifilm served around 9,000 patients throughout Switzerland, thus increasingly easing the burden of carers in care homes or hospitals responsible for adminis- tering medications by hand. After some delay, the company will roll out a new generation of blistering machines in 2019 that will double the number of blistered units per hour. They are also more precise than the current equipment and can produce sachets labelled in three languages. To ensure high quality and that the strong demand can be met, Medifilm used two additional conventional machines in the year under review. Important progress at HCI Solutions HCI Solutions has become the central master data special- ist within the Galenica Group. In this role, it supported the further development of the online shops and Click & Collect. It also intensively stepped up the expansion of the image database so that the necessary images for the Amavita, Sun Store and Coop Vitality online offerings are available. To this end, products are photographed according to a defined standard. As of the end of 2018, around 50,000 images were already available. The plan is to also offer these images to other interested customers in the online sales market at a later time. The registration of e-Medication solution Documedis ® from HCI Solutions as a Class I medical device was confirmed by the Swiss Agency for Therapeutic Products, Swissmedic, in the year under review. This is thanks to its Clinical Decision Support (CDS) functions, which allow a detailed, patient- specific risk assessment of a medication and provide indications for adjusting drug therapy. Following an initial pilot phase in the hospital region of St. Gallen, Documedis ® is now used in various hospitals and care homes throughout Switzerland. Documedis ® is also fully integrated in the Triapharm ® phar- macy software and therefore used at all Amavita, Sun Store and Coop Vitality points of sale. “Galexis launched the new pharmaceutical and OTC own brand ‘Felan’ for independent pharmacies in 2018 and is thereby supporting them in positioning themselves in the eyes of their customers and strengthening customer loyalty.” Services Segment – Services Business sector 1,671 Galenica Group 6,580 2,372.3 Galenica Group CHF 3,165.0 million Companies – Alloga Ltd., www.alloga.ch – Galexis Ltd., www.galexis.com – HCI Solutions Ltd., www.hcisolutions.ch – Medifilm Ltd., www.medifilm.ch – Pharmapool Ltd., www.pharmapool.ch – Unione Farmaceutica Distribuzione Ltd., www.ufd.swiss Number of employees Net sales in million CHF Services